
Lumigan Eye Drop
Marketer
Allergan India Pvt Ltd
Salt Composition
Bimatoprost (0.03% w/v)
Overview Lumigan Eye Drop
Bimatoprost ophthalmic solution is prescribed to lower intraocular pressure in adults diagnosed with glaucoma or ocular hypertension. Elevated eye pressure can harm vision, potentially causing irreversible blindness. This medication facilitates the outflow of aqueous humor from the eye into the bloodstream. Appropriate for both adult and pediatric patients, bimatoprost can be administered alone or in conjunction with other ophthalmic treatments. Adhere strictly to your physician's instructions, ensuring consistent use for optimal efficacy. Discontinuation may lead to a rise in intraocular pressure and subsequent visual impairment. Discard any bottle with a compromised seal. Remove contact lenses prior to application and reinsert after a minimum 15-minute waiting period. Commonly reported adverse reactions include conjunctival redness and ocular pruritus. Report any side effects to your doctor; they can offer strategies for mitigation or explore alternative therapies. Refrain from driving if experiencing blurred vision or other visual disturbances until your sight returns to normal. This visual impairment is typically transient.
Uses of Lumigan Eye Drop
Elevated intraocular pressure/Glaucoma
Major Benefits of Lumigan Eye Drop:
Apply this medication solely to the outer skin. Administer as directed by your physician, adhering to the prescribed dosage and treatment schedule. Consult the product label for complete application instructions. Position the dropper near the eye, ensuring no contact. Carefully depress the dropper to instill the medication beneath the lower eyelid. Remove any excess solution.
Common Side effects of Lumigan Eye Drop:
- Conjunctival hyperemia
- Eye itching
How to use Lumigan Eye Drop:
Apply this medication topically only. Administer the prescribed dosage for the specified duration as directed by your physician. Always consult the product label for application instructions prior to use. Position the dropper near the eye, avoiding contact. Carefully dispense the medication into the lower conjunctival sac. Remove any excess solution.
How Lumigan Eye Drop works:
Latisse ophthalmic solution, a prostaglandin analog, reduces elevated intraocular pressure by enhancing aqueous humor drainage.
SAFETY ADVICE
AlcoholNone
No drug interactions identified.
PregnancySAFE IF PRESCRIBED
Latisse ophthalmic solution poses minimal risk to the fetus during gestation, according to the majority of research.
Breast feedingSAFE IF PRESCRIBED
Latisse ophthalmic solution is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant. To minimize potential breast milk exposure, apply pressure to the inner eye corner for at least one minute following administration, then gently blot away any residual solution.
DrivingUNSAFE
Following application of Lumigan eye drops, temporary blurred vision may occur. Refrain from driving until your vision is restored.
KidneyNone
No known drug interactions.
LiverNone
No known drug interactions.
What if you forget to take Lumigan Eye Drop :
Omit any missed Lumigan Eye Drop dose and resume your regular application schedule. Avoid administering a double dose.
Facts to Know About Lumigan Eye Drop
| Label | Value |
|---|---|
| Type of Compound | Prostanoid agonist |
| Potential for Dependence | None. |
| Type of Medication | Eye medication |
| Mechanism of Action | Prostaglandin F2α analog |
